# Trade Mark Journal No.2025/034 22 August 2025

## WO0000001868001 (5)

Office of origin: United States of America

Date of International Registration:25 April 2025
Date of designation in the UK: 25 April 2025

International priority date claimed: 8 November 2024 (United States of America) (98844270)

Class 5
  Pharmaceutical preparations to treat Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia; pharmaceutical preparations for the treatment of orphan diseases.

Soleno Therapeutics, Inc.

Representative: John Paul Oleksiuk Cooley LLP, 1299 PENNSYLVANIA AVENUE, NW, SUITE 700,, ATTN: IP DOCKETING DEPARTMENT, Washington DC 20004-2400, UNITED STATES OF AMERICA